During the past decade, Prahran Market Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prahran Market Clinic" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Kirby Institute" with 4 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "University of Minnesota" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prahran Market Clinic" #1 collaborator was "The Alfred" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Prahran Market Clinic" are "HIV Infections" (13 trials), "HIV" (5 trials), "HIV Infection" (2 trials), "Hepatitis C" (2 trials) and "Acquired Immunodeficiency Syndrome" (1 trials). Many other conditions were trialed in "Prahran Market Clinic" in a lesser frequency.

Most popular intervention types in "Prahran Market Clinic" are "Drug" (12 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (2 trials), "FTC/TDF" (2 trials), "ATV" (1 trials), "Abacavir 600mg - Lamivudine 300mg" (1 trials) and "All licensed antiretroviral medications" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prahran Market Clinic" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Prahran Market Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Prahran Market Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Prahran Market Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".